Acción PRTC PURETECH HEALTH PLC
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas PureTech Health plc

Acciones

PRTC

GB00BY2Z0H74

Mercado cerrado - London S.E.
Otros sitios de cotización
 17:35:13 05/06/2024 		Varia. Cinco días. Varia. 1 de enero.
232 GBX +0,22 % Gráfico intradía de PureTech Health plc +1,53 % +19,46 %
29/05 Ankili, de PureTech, sera adquirida por Virtual Therapeutics AN
21/05 Vedanta, fundada por PureTech, inicia los ensayos de un fármaco contra la bacteria colónica VE303 AN

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!
Inscripción 100% Gratuita
PureTech's Ankili to be acquired by Virtual Therapeutics
PureTech Health's Akili, Virtual Therapeutics Sign Merger Deal to Launch Digital Health Company
PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company
PureTech to Present at the Jefferies Global Healthcare Conference
PureTech-founded Vedanta begins trials for VE303 colonic bacteria drug
PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection
PureTech Health Opens $100 Million Buyback Program
PureTech Health Launches $100 Million Share Repurchase
PureTech Health launches USD100 million buyback programme
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share
PureTech Health plc announces an Equity Buyback for 33,500,000 shares, representing 12.37% for $100 million.
PureTech Health : Shareholder Circular regarding Proposed Tender Offer
PureTech Health plc authorizes a Buyback Plan.
EARNINGS AND TRADING: Asiamet Resources declares special dividend
EARNINGS AND TRADING: Asiamet Resources declares special dividend
PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry Annual Meeting
PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
Seaport Therapeutics Announces Board of Directors Changes and Makes Key Executive Appointments
Tranche Update on PureTech Health plc's Equity Buyback Plan announced on May 5, 2022.
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción PRTC
  4. Noticias PureTech Health plc
  5. Otros idiomas
-40% Prolongación excepcional: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA